Doll; Ronald J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Doll; Ronald J..The latest application filed is for "2,6,7,8 substituted purines as hdm2 inhibitors".

Company Profile

0.81.65

Doll; Ronald J. - Convent Station NJ
Doll; Ronald J. - Kenilworth NJ
Doll; Ronald J. - Cedarburg WI
Doll; Ronald J. - Maplewood NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted pyrrolopyrimidines as HDM2 inhibitors Grant 9,637,493 - Dinsmore , et al. May 2, 2	2017-05-02
2,6,7,8 substituted purines as HDM2 inhibitors Grant 9,540,377 - Cammarano , et al. January 10, 2	2017-01-10
2,6,7,8 Substituted Purines As Hdm2 Inhibitors App 20150353553 - Cammarano; Carolyn Michele ; et al.	2015-12-10
Substituted Pyrrolopyrimidines As Hdm2 Inhibitors App 20150329548 - Dinsmore; Christopher ; et al.	2015-11-19
Macrocycles that increase p53 activity and the uses thereof Grant 8,987,274 - Nair , et al. March 24, 2	2015-03-24
Substituted imidazopyridines as HDM2 inhibitors Grant 8,962,611 - Christopher , et al. February 24, 2	2015-02-24
Substituted Imidazopyridines As Hdm2 Inhibitors App 20140357618 - Christopher; Matthew P. ; et al.	2014-12-04
SUBSTITUTED PIPERIDINES THAT INCREASE p53 ACTIVITY AND THE USES THEREOF App 20140336222 - Bogen; Stephane L. ; et al.	2014-11-13
MACROCYCLES THAT INCREASE p53 ACTIVITY AND THE USES THEREOF App 20140315916 - Nair; Latha G. ; et al.	2014-10-23
Substituted piperidines that increase p53 activity and the uses thereof Grant 8,859,776 - Bogen , et al. October 14, 2	2014-10-14
Substituted imidazopyridines as HDM2 inhibitors Grant 8,846,657 - Christopher , et al. September 30, 2	2014-09-30
Substituted Imidazopyridines as HDM2 Inhibitors App 20140179680 - Christopher; Matthew P. ; et al.	2014-06-26
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors Grant 8,673,924 - Guzi , et al. March 18, 2	2014-03-18
Compounds that are ERK inhibitors Grant 8,658,651 - Zhu , et al. February 25, 2	2014-02-25
N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1 Grant 8,623,857 - Tsui , et al. January 7, 2	2014-01-07
Compounds that are ERK inhibitors Grant 8,546,404 - Cooper , et al. October 1, 2	2013-10-01
N-phenyl Imidazole Carboxamide Inhibitors Of 3-phosphoinositide-dependent Protein Kinase-1 App 20130079326 - Tsui; Hon-Chung ; et al.	2013-03-28
Inhibitors of Phosphoinositide Dependent Kinase 1 (PDK1) App 20130053382 - Paliwal; Sunil ; et al.	2013-02-28
Novel Compounds That Are Erk Inhibitors App 20120214823 - Zhu; Hugh Y. ; et al.	2012-08-23
Substituted Piperidines That Increase P53 Activity And The Uses Thereof App 20120208844 - Bogen; Stephane L. ; et al.	2012-08-16
Novel Compounds That Are Erk Inhibitors App 20110189192 - Cooper; Alan B. ; et al.	2011-08-04
Heterocyclic Compounds And Use Thereof As Erk Inhibitors App 20110038876 - Sun; Robert ; et al.	2011-02-17
Substituted piperidines that increase P53 activity and the uses thereof Grant 7,884,107 - Ma , et al. February 8, 2	2011-02-08
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,807,683 - Guzi , et al. October 5, 2	2010-10-05
Pyrrolo [3, 2-a] Pyridine Derivatives For Inhibiting Ksp Kinesin Activity App 20100068181 - Paliwal; Sunil ; et al.	2010-03-18
Compounds for inhibiting KSP kinesin activity Grant 7,608,643 - Doll , et al. October 27, 2	2009-10-27
Farnesyl protein transferase inhibitors as antitumor agents Grant 7,557,107 - Zhu , et al. July 7, 2	2009-07-07
Novel compounds that are ERK inhibitors App 20090118284 - Cooper; Alan B. ; et al.	2009-05-07
Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,514,442 - Guzi , et al. April 7, 2	2009-04-07
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,511,049 - Guzi , et al. March 31, 2	2009-03-31
17.beta.-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases Grant 7,485,645 - Guzi , et al. February 3, 2	2009-02-03
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,470,695 - Guzi , et al. December 30, 2	2008-12-30
Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,468,372 - Guzi , et al. December 23, 2	2008-12-23
Imidazopyridines as cyclin dependent kinase inhibitors Grant 7,452,902 - Dwyer , et al. November 18, 2	2008-11-18
17.beta.-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases Grant 7,432,268 - Guzi , et al. October 7, 2	2008-10-07
Imidazopyrazines as cyclin dependent kinase inhibitors Grant 7,432,265 - Paruch , et al. October 7, 2	2008-10-07
Farnesyl protein transferase inhibitors as antitumor agents Grant 7,342,016 - Zhu , et al. March 11, 2	2008-03-11
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20080050384 - Guzi; Timothy J. ; et al.	2008-02-28
Substituted Piperidines that Increase P53 Activity and the Uses Thereof App 20080004287 - Ma; Yao ; et al.	2008-01-03
17beta-hydroxysteroid Dehydrogenase Type 3 Inhibitors For The Treatment Of Androgen Dependent Diseases App 20080004248 - Guzi; Timothy J. ; et al.	2008-01-03
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,309,705 - Guzi , et al. December 18, 2	2007-12-18
PYRAZOLO[1,5-a]PYRIMIDINES App 20070275963 - Guzi; Timothy J. ; et al.	2007-11-29
Novel Pyrazolopyrimidines As Cyclin Dependent Kinase Inhibitors App 20070275983 - Guzi; Timothy J. ; et al.	2007-11-29
Adjustable guard for protecting coupling connection between rotating shafts Grant 7,275,995 - Doll October 2, 2	2007-10-02
Metabolites of tricyclic amides useful for inhibition of G-protein function and methods of treatment of proliferative diseases Grant 7,271,174 - Chowdhury , et al. September 18, 2	2007-09-18
17.beta.-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases Grant 7,271,175 - Guzi , et al. September 18, 2	2007-09-18
Novel Imidazopyrazines As Cyclin Dependent Kinase Inhibitors App 20070155751 - PARUCH; KAMIL ; et al.	2007-07-05
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20070054906 - Guzi; Timothy J. ; et al.	2007-03-08
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20070054925 - Guzi; Timothy J. ; et al.	2007-03-08
Imidazopyrazines as cyclin dependent kinase inhibitors Grant 7,186,740 - Paruch , et al. March 6, 2	2007-03-06
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20070037824 - Guzi; Timothy J. ; et al.	2007-02-15
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,161,003 - Guzi , et al. January 9, 2	2007-01-09
Pyrazolopyridines as cyclin dependent kinase inhibitors Grant 7,151,104 - Dwyer , et al. December 19, 2	2006-12-19
17 .beta.-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases Grant 7,138,396 - Guzi , et al. November 21, 2	2006-11-21
Compounds for inhibiting KSP kinesin activity App 20060258699 - Doll; Ronald J. ; et al.	2006-11-16
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20060235025 - Guzi; Timothy J. ; et al.	2006-10-19
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,119,200 - Guzi , et al. October 10, 2	2006-10-10
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20060178371 - Guzi; Timothy J. ; et al.	2006-08-10
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20060173017 - Guzi; Timothy J. ; et al.	2006-08-03
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20060173016 - Guzi; Timothy J. ; et al.	2006-08-03
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,084,271 - Guzi , et al. August 1, 2	2006-08-01
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,078,525 - Guzi , et al. July 18, 2	2006-07-18
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,074,924 - Guzi , et al. July 11, 2	2006-07-11
Adjustable rotating shaft guard App 20060144201 - Doll; Ronald J.	2006-07-06
17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases App 20060142338 - Guzi; Timothy J. ; et al.	2006-06-29
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,067,661 - Guzi , et al. June 27, 2	2006-06-27
17 .beta.-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases Grant 7,053,091 - Guzi , et al. May 30, 2	2006-05-30
17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases App 20060069103 - Guzi; Timothy J. ; et al.	2006-03-30
Novel imidazopyridines as cyclin dependent kinase inhibitors App 20060030555 - Dwyer; Michael P. ; et al.	2006-02-09
Imidazopyridines as cyclin dependent kinase inhibitors Grant 6,992,080 - Dwyer , et al. January 31, 2	2006-01-31
17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases App 20060014755 - Guzi; Timothy J. ; et al.	2006-01-19
Imidazopyrazines as cyclin dependent kinase inhibitors Grant 6,919,341 - Paruch , et al. July 19, 2	2005-07-19
Novel imidazopyrazines as cyclin dependent kinase inhibitors App 20050130980 - Paruch, Kamil ; et al.	2005-06-16
17.beta.-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases Grant 6,903,102 - Guzi , et al. June 7, 2	2005-06-07
Novel farnesyl protein transferase inhibitors as antitumor agents App 20050059672 - Zhu, Hugh Y. ; et al.	2005-03-17
Metabolites of tricyclic amides useful for inhibition of G-protein function and methods of treatment of proliferative diseases App 20040266810 - Chowdhury, Swapan K. ; et al.	2004-12-30
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20040209878 - Guzi, Timothy J. ; et al.	2004-10-21
Farnesyl protein transferase inhibitors Grant 6,800,636 - Guzi , et al. October 5, 2	2004-10-05
Compounds useful for inhibition of farnesyl protein transferase App 20040157872 - Cooper, Alan B. ; et al.	2004-08-12
17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases App 20040138226 - Guzi, Timothy J. ; et al.	2004-07-15
17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases App 20040132736 - Guzi, Timothy J. ; et al.	2004-07-08
Novel farnesyl protein transferase inhibitors as antitumor agents App 20040122018 - Zhu, Hugh Y. ; et al.	2004-06-24
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20040116442 - Guzi, Timothy J. ; et al.	2004-06-17
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20040106624 - Guzi, Timothy J. ; et al.	2004-06-03
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20040102452 - Guzi, Timothy J. ; et al.	2004-05-27
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20040102451 - Guzi, Timothy J. ; et al.	2004-05-27
Farnesyl protein transferase inhibitors Grant 6,740,661 - Taveras , et al. May 25, 2	2004-05-25
Novel imidazopyridines as cyclin dependent kinase inhibitors App 20040097517 - Dwyer, Michael P. ; et al.	2004-05-20
Novel pyrazolopyridines as cyclin dependent kinase inhibitors App 20040097516 - Dwyer, Michael P. ; et al.	2004-05-20
Novel imidazopyrazines as cyclin dependent kinase inhibitors App 20040072835 - Paruch, Kamil ; et al.	2004-04-15
Novel imidazopyrazines as cyclin dependent kinase inhibitors App 20040063715 - Paruch, Kamil ; et al.	2004-04-01
Compounds useful for inhibition of farnesyl protein transferase Grant 6,689,789 - Cooper , et al. February 10, 2	2004-02-10
Novel farnesyl protein transferase inhibitors as antitumor agents App 20030229099 - Zhu, Hugh Y. ; et al.	2003-12-11
Adjustable guard for protecting coupling connection between rotating shafts App 20030216187 - Doll, Ronald J.	2003-11-20
Compounds useful for inhibition of farnesyl protein transferase App 20030092726 - Cooper, Alan B. ; et al.	2003-05-15
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases App 20030055065 - Bishop, W. Robert ; et al.	2003-03-20
Farnesyl protein transferase inhibitors App 20030040520 - Guzi, Timothy ; et al.	2003-02-27
Novel farnesyl protein transferase inhibitors as antitumor agents App 20020198216 - Njoroge, F. George ; et al.	2002-12-26
Farnesyl protein transferase inhibitors App 20020103207 - Taveras, Arthur G. ; et al.	2002-08-01
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases App 20020068742 - Bishop, W. Robert ; et al.	2002-06-06
Compounds useful for inhibition of farnesyl protein transferase Grant 6,387,905 - Njoroge , et al. May 14, 2	2002-05-14
Farnesyl protein transferase inhibitors Grant 6,372,747 - Taveras , et al. April 16, 2	2002-04-16
Farnesyl protein transferase inhibitors Grant 6,362,188 - Guzi , et al. March 26, 2	2002-03-26
Compounds useful for inhibition of farnesyl protein transferase App 20020019400 - Njoroje, FGeorge ; et al.	2002-02-14
Compounds useful for inhibition of farnesyl protein transferase App 20010039283 - Cooper, Alan B. ; et al.	2001-11-08
Compounds useful for inhibition of farnesyl protein transferase App 20010014681 - Doll, Ronald J. ; et al.	2001-08-16
Compounds useful for inhibition of farnesyl protein transferase App 20010007870 - Remiszewski, Stacy W. ; et al.	2001-07-12
Compounds useful for inhibition of farnesyl protein transferase Grant 6,239,140 - Cooper , et al. May 29, 2	2001-05-29
Compounds useful for inhibition of farnesyl protein transferase Grant 6,228,856 - Njoroge , et al. May 8, 2	2001-05-08
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseases Grant 6,143,758 - Doll , et al. November 7, 2	2000-11-07
Compounds useful for inhibition of farnesyl protein transferase Grant 6,124,295 - Taveras , et al. September 26, 2	2000-09-26
Method for treating proliferative diseases Grant 6,096,757 - Bishop , et al. August 1, 2	2000-08-01
Compounds useful for inhibition of farnesyl protein transferase Grant 6,030,982 - Njoroge , et al. February 29, 2	2000-02-29
Tricyclic antitumor farnesyl protein transferase inhibitors Grant 5,994,364 - Njoroge , et al. November 30, 1	1999-11-30
Tricyclic compounds useful as inhibitors of farnesyl-protein transferase Grant 5,958,940 - Rane , et al. September 28, 1	1999-09-28
Compounds useful for inhibition of farnesyl protein transferase Grant 5,945,429 - Taveras , et al. August 31, 1	1999-08-31
Benzo (5,6) cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors Grant 5,939,416 - Rane , et al. August 17, 1	1999-08-17
Keto amide derivatives useful as farnesyl protein transferase inhibitors Grant 5,925,639 - Doll , et al. July 20, 1	1999-07-20
Tricyclic compounds Grant 5,891,872 - Doll , et al. April 6, 1	1999-04-06
Carbonyl piperazinyl and piperidinyl compounds Grant 5,880,128 - Doll , et al. March 9, 1	1999-03-09
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease Grant 5,874,442 - Doll , et al. February 23, 1	1999-02-23
Tricyclic amide and urea compounds, useful inhibition of g-protein function and for treatment of proliferative diseases Grant 5,807,853 - Bishop , et al. September 15, 1	1998-09-15
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases Grant 5,801,175 - Afonso , et al. September 1, 1	1998-09-01
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases Grant 5,728,703 - Bishop , et al. March 17, 1	1998-03-17
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases Grant 5,721,236 - Bishop , et al. February 24, 1	1998-02-24
Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases Grant 5,719,148 - Bishop , et al. February 17, 1	1998-02-17
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases Grant 5,714,609 - Doll , et al. February 3, 1	1998-02-03
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases Grant 5,700,806 - Doll , et al. December 23, 1	1997-12-23
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases Grant 5,696,121 - Bishop , et al. December 9, 1	1997-12-09
Tricyclic sulfonamide compounds useful for inhibition of G-protein function and for treatment of proliferative diseases Grant 5,661,152 - Bishop , et al. August 26, 1	1997-08-26
Phosphodiesterase inhibitors Grant 5,091,431 - Tulshian , et al. February 25, 1	1992-02-25
Phosphodiesterase inhibitors having an optionally substituted purine derivative portion and a benzo- or cyclopenta-furan portion Grant 4,971,972 - Doll , et al. November 20, 1	1990-11-20
Mercapto-acylamino acids as antihypertensives Grant 4,879,309 - Doll , et al. November 7, 1	1989-11-07
Antihypertensive acylpyrazines Grant 4,803,206 - Magatti , et al. February 7, 1	1989-02-07
Antiglaucoma compositions and methods Grant 4,783,444 - Watkins , et al. November 8, 1	1988-11-08
Antihypertensive agents Grant 4,431,644 - Smith , et al. February 14, 1	1984-02-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.